SOUTHWEST ONCOLOGY GROUP -UNIVERSITY OF CALIFORNIA,

Project: Research project

Project Details

Description

This grant proposal represents the University of California, Davis'
request for funded participation in the Southwest Oncology Group
(SWOG). Under the auspices of this grant, two major institutions,
the University Medical Center in Sacramento (UCDMC) and the
Veteran's Administration Medical Center in Martinez (MVAMC),
in collaboration with private practice physicians throughout the
northern central valley, will coordinate clinical trials activities in
an eight county area serving a population of greater than two
million. UC Davis was a very active participant in the Northern California
Oncology Group. It is our goal to continue this participation with
our recent acceptance into the Southwest Oncology Group. Our
clinical trials network remains in place. We anticipate a
combined institutional accrual of 150 patients per year on NCI
approved protocols. Our activities will be enhanced by a new
40,000 sq. ft. Cancer Treatment Facility that will include a
Radiation Oncology Center, scheduled to open at UCDMC in early
1988. We have already begun to provide clinical expertise to SWOG in
the areas of GU oncology, lung cancer and hematologic oncology.
This clinical expertise is supported by laboratory-based
investigations. We are participants in the Bladder Cancer Flow
Cytometry network (R01 funded). Dr. Ralph deVere White has
been named Chair of the SWOG GU Subcommittee on Flow
Cytometry. Dr. Jerry Lewis is a member of the SWOG Leukemia
Subcommittee on Cytogenetics. We have proposed three trials for
SWOG consideration. Therapeutic approaches to cancer initiated
at UC Davis include monoclonal antibody imaging and therapy
trials; high dose platinum (day 1 & 8) in lung cancer; and
carboplatinum in relapsed ANLL. Our SWOG membership will be one important effort to ensure the
widespread dissemination of state-of-the-art cancer care and
cancer control throughout the northern central valley of
California.
StatusFinished
Effective start/end date1/1/8812/31/15

Funding

  • National Institutes of Health
  • National Institutes of Health: $435,092.00
  • National Institutes of Health
  • National Institutes of Health: $299,584.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $348,516.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $330,569.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $314,015.00
  • National Institutes of Health
  • National Institutes of Health: $306,945.00
  • National Institutes of Health
  • National Institutes of Health: $344,197.00
  • National Institutes of Health: $326,804.00
  • National Institutes of Health: $108,773.00
  • National Institutes of Health: $314,107.00
  • National Institutes of Health: $387,416.00
  • National Institutes of Health
  • National Institutes of Health: $299,556.00
  • National Institutes of Health: $343,423.00
  • National Institutes of Health: $316,709.00
  • National Institutes of Health
  • National Institutes of Health: $316,002.00
  • National Institutes of Health: $25,000.00

ASJC

  • Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.